Latham & Watkins

Firm overview:

Latham & Watkins has significant trial experience and a winning track record across US and global venues on the most complex patent disputes, often involving technologies developed around the globe. Its reputation of success has led clients facing long odds to hand over critical IP cases midway and the firm emphasises its “willingness to go to trial”.

Latham deploys trial counsel experienced in the relevant jurisdiction for patent cases, such as the Eastern District of Texas, the District Courts of California, the International Trade Commission, the Federal Circuit, or numerous global venues.

The firm also regularly achieves successful results in patent mediations, arbitrations, and other forms of alternative dispute resolution as an alternative to protracted litigation.

Team overview:

Key contacts at Lathams on patents litigation are Doug Lumish in Silicon Valley, and Matthew Moore and Michael Morin in DC.

Distinguished trial lawyer Lumish has gained national recognition for his winning track record at all stages of litigation. Amazon, Google, Meta, Peloton and Disney have all enlisted his assistance for patent matters, and he has served terms as global vice chair of Latham’s Litigation and Trial Department, global co-chair of the IP Litigation Practice, and co-chair of the Bay Area Litigation & Trial Department.

Key matters:

● Eolas Techs v Amazon.com (23-1184).

Latham & Watkins’ Gabriel Bell represents Amazon in this matter involving an early-internet patent that Amazon, Google and Walmart were accused of infringing. In October 2024 the US Supreme Court rejected Eolas Technologies’ bid for reconsideration of a lower court’s ruling that invalidated the patent.

● Nippon Shinyaku v Sarepta Therapeutics et al, case number 1:21-cv-01015, in the US District Court for the District of Delaware.

Michael Morin and David Frazier of Latham & Watkins, along with William Raich of Finnegan, secured a $115.2 million damages award for client Sarepta in a patent infringement suit concerning a treatment for Duchenne muscular dystrophy.

Clients:

Amazon Technologies, Sarepta, Serendia, UWA.